R. Valtola

Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas

A. Folpe, T. Veikkola, S. Weiss, 2000, Modern Pathology.

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.

K. Alitalo, J. Taipale, P. Heikkilä, 1999, The American journal of pathology.

Prognosis of breast‐carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular‐endothelial‐growth‐factor receptor 3

D. Birnbaum, V. Bardou, P. Viens, 2000, International journal of cancer.

Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis

C. Fujiyama, S. Fuggle, H. Turley, 2000, BJU international.

Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.

E. Tschachler, K. Alitalo, P. Heikkilä, 1998, Cancer research.

Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome.

C. Print, K. Lessan, A. Evans, 2004, Human reproduction.